New Developments in Peptide Receptor Radionuclide Therapy

Guillaume P. Nicolas; Alfred Morgenstern; Margret Schottelius; Melpomeni Fani

doi:10.2967/jnumed.118.213496

Research ArticleFocus on Molecular Imaging

New Developments in Peptide Receptor Radionuclide Therapy

Guillaume P. Nicolas, Alfred Morgenstern, Margret Schottelius and Melpomeni Fani

Journal of Nuclear Medicine February 2019, 60 (2) 167-171; DOI: https://doi.org/10.2967/jnumed.118.213496

Guillaume P. Nicolas

1Division of Nuclear Medicine, University Hospital Basel, University of Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alfred Morgenstern

2Joint Research Centre, Directorate for Nuclear Safety and Security, European Commission, Karlsruhe, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Margret Schottelius

3Institute of Pharmaceutical Radiochemistry, Technische Universität München, Garching, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Melpomeni Fani

4Division of Radiopharmaceutical Chemistry, University Hospital Basel, University of Basel, Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 2

February 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following New Developments in Peptide Receptor Radionuclide Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

New Developments in Peptide Receptor Radionuclide Therapy

Guillaume P. Nicolas, Alfred Morgenstern, Margret Schottelius, Melpomeni Fani

Journal of Nuclear Medicine Feb 2019, 60 (2) 167-171; DOI: 10.2967/jnumed.118.213496

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

New Developments in Peptide Receptor Radionuclide Therapy

Guillaume P. Nicolas, Alfred Morgenstern, Margret Schottelius, Melpomeni Fani

Journal of Nuclear Medicine Feb 2019, 60 (2) 167-171; DOI: 10.2967/jnumed.118.213496

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

177Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods
A Gallium-68-Labeled Peptide Radiotracer For CD38-Targeted Imaging In Multiple Myeloma With PET
Production and Supply of {alpha}-Particle-Emitting Radionuclides for Targeted {alpha}-Therapy

Google Scholar

Keywords

targeted radionuclide therapy
theranostics
G-protein coupled receptors
beta radiation therapy
alpha radiation therapy

Main menu

User menu

Search

New Developments in Peptide Receptor Radionuclide Therapy

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords